NCT06994403

Brief Summary

Carob (Ceratonia siliqua) is a fruit traditionally used in various Mediterranean countries for the preparation of sweets and beverages. Its pulp, once the seeds are removed, is milled into carob flour, a nutrient-rich food containing fiber, carbohydrates, proteins, and essential minerals such as potassium, magnesium, sodium, phosphorus, and calcium. Carob flour is also naturally sweet and can serve as a cocoa powder substitute in desserts. Furthermore, it is a source of polyphenols with known antioxidant properties. Clinical evidence suggests that consumption of foods rich in refined carbohydrates is associated with elevated postprandial blood glucose levels, which are recognized as an independent cardiovascular risk factor. The glycemic index (GI) is a useful parameter to assess the impact of carbohydrate-containing foods on postprandial glycemic response. Based on carbohydrate quality, foods are classified as having high, medium, or low GI. Consumption of high-GI foods leads to a stronger glycemic response and has been linked to increased risk of chronic conditions such as type 2 diabetes, obesity, and cardiovascular disease. Given its bromatological profile, carob flour may have the potential to modulate postprandial glycemic responses. However, studies evaluating the GI of carob-based products have shown inconsistent findings. In one randomized trial involving 10 healthy adults, a carob-based snack demonstrated a lower GI (40) compared to a chocolate cookie with an equivalent carbohydrate content (GI 78), using glucose as the reference. The same study found that consuming the carob snack before a meal led to a reduced postprandial glycemic response, decreased hunger, and lower caloric intake at an ad libitum meal. Another study on 7 healthy individuals reported a GI of 39 for carob flour bars containing 26 g of available carbohydrates. Conversely, a study involving 20 healthy participants found that consuming 5 or 10 g of carob pulp with 200 mL of water and 50 g glucose increased postprandial glycemic and insulinemic responses compared to water and glucose alone. This effect was not observed with a 20 g dose of carob pulp. Among carbohydrate-rich foods, pasta represents a key component of the Italian diet and, due to its physical structure, generally has a low-to-moderate GI. Compared to other wheat-based foods like bread, pasta tends to produce a lower postprandial glycemic response when carbohydrate content is matched. However, the impact of adding carob flour to durum wheat semolina in pasta production on postprandial glycemia remains unexplored. The current research project consists of two studies. The first study aims to determine the glycemic index of carob-enriched durum wheat pasta in healthy adult volunteers, using white bread as the reference food. The second study investigates the postprandial glycemic response to the same carob-enriched pasta in individuals with type 1 diabetes, comparing it to traditional durum wheat pasta. These studies are designed to contribute to the understanding of carob flour's role in glycemic control, with potential implications for dietary management in both healthy individuals and patients with diabetes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Sep 2023Dec 2026

Study Start

First participant enrolled

September 4, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 20, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 29, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

3 years

First QC Date

May 20, 2025

Last Update Submit

May 20, 2025

Conditions

Keywords

Ceratonia siliquaGlycemic IndexType 1 DiabetesFunctional FoodsPostprandial Glycemia

Outcome Measures

Primary Outcomes (1)

  • Glycemic Index of Carob-Enriched Durum Wheat Pasta

    The primary outcome is the determination of the glycemic index (GI) of a carob-enriched durum wheat pasta compared to white bread, used as the reference food. The glycemic response will be assessed through blood glucose concentrations measured at fasting and at 15, 30, 60, 90, and 120 minutes after consumption.

    Within 2 hours after consumption of the test meal on three separate test days (each separated by at least 2 days).

Other Outcomes (1)

  • Postprandial Glycemic Response (iAUC) to Carob-Enriched Pasta in Type 1 Diabetes

    6 hours post-meal on 6 different test days over a 2-week period.

Study Arms (3)

Carob-Enriched Durum Wheat Pasta

EXPERIMENTAL

Participants will consume 68 g of carob-enriched durum wheat pasta (231 kcal) containing 50 g of available carbohydrates, served with 55 g of tomato sauce prepared with 2.5 g of extra virgin olive oil.

Dietary Supplement: Durum wheat pasta enriched with carob flourDietary Supplement: Standard durum wheat pastaDietary Supplement: White bread reference meal

Durum Wheat Pasta

SHAM COMPARATOR

Participants will consume 63 g of traditional durum wheat pasta (221 kcal) containing 50 g of available carbohydrates, served with 55 g of tomato sauce prepared with 2.5 g of extra virgin olive oil.

Dietary Supplement: Durum wheat pasta enriched with carob flourDietary Supplement: Standard durum wheat pastaDietary Supplement: White bread reference meal

White Bread (Reference Food)

ACTIVE COMPARATOR

Participants will consume 84 g of white bread (225 kcal) containing 50 g of available carbohydrates, served with 55 g of tomato sauce prepared with 2.5 g of extra virgin olive oil.

Dietary Supplement: Durum wheat pasta enriched with carob flourDietary Supplement: Standard durum wheat pastaDietary Supplement: White bread reference meal

Interventions

Participants will consume 68 g of durum wheat pasta enriched with carob flour (231 kcal), providing 50 g of available carbohydrates. The pasta will be served with 55 g of tomato sauce prepared with 2.5 g of extra virgin olive oil.

Carob-Enriched Durum Wheat PastaDurum Wheat PastaWhite Bread (Reference Food)
Standard durum wheat pastaDIETARY_SUPPLEMENT

Participants will consume 63 g of standard durum wheat pasta (221 kcal), providing 50 g of available carbohydrates. The pasta will be served with 55 g of tomato sauce prepared with 2.5 g of extra virgin olive oil.

Carob-Enriched Durum Wheat PastaDurum Wheat PastaWhite Bread (Reference Food)
White bread reference mealDIETARY_SUPPLEMENT

Participants will consume 84 g of white bread (225 kcal), providing 50 g of available carbohydrates. The bread will be served with 55 g of tomato sauce prepared with 2.5 g of extra virgin olive oil.

Carob-Enriched Durum Wheat PastaDurum Wheat PastaWhite Bread (Reference Food)

Eligibility Criteria

Age18 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Study 1
  • Healthy male volunteers
  • Age between 18 and 50 years
  • Body Mass Index (BMI) between 18 and 29 kg/m²
  • Study 2
  • Male and female individuals
  • Age ≥ 18 years
  • Confirmed diagnosis of type 1 diabetes mellitus
  • Use of a continuous glucose monitoring (CGM) system

You may not qualify if:

  • Study 1
  • Diagnosis of diabetes mellitus
  • Presence of any chronic-degenerative disease
  • Any acute or chronic medical condition that could seriously compromise overall health
  • Diagnosis of celiac disease
  • Study 2
  • Presence of serious chronic illnesses (e.g., coronary heart disease, renal failure, liver diseases, endocrine disorders)
  • Gastrointestinal disorders
  • Pregnancy or breastfeeding
  • Alcohol or drug dependence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federico II University

Napoli, 80131, Italy

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

locust bean gum

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Giuseppina Costabile

    Federico II University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 20, 2025

First Posted

May 29, 2025

Study Start

September 4, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 29, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations